[wadiz] Transparency Report Vol. 06

#TRUST & SAFETY · Platform Operational Status Report — Vol.06

From pre-approval to full-course AI monitoring.
I am sharing the results of this week's action for platform trust.

01 · Current status of AI monitoring operations this week

I share a representative case of action based on this week's operational policy.

CASE 01\n Case of Functional Cosmetics Efficacy Advertising

Beauty / Display advertising method / Cosmetic method /\n Modification

01 · Sensing

AI Monitoring

Monitoring to confirm the expression of story advertisements that may deviate from the scope of examination and reporting of functional cosmetics for which objective evidence has not been verified or may be mistaken for drug/procedure effects\n effects

02 · Review

Review of operators and supplement data

Based on the AI monitoring results, the story and reward information was reviewed, and the expression that definitively guarantees efficacy\n and the comparison expression with medical procedures\n were reviewed

03 · Measures

Request to modify the story

Request for modification of expressions that may exceed the efficacy range of functional cosmetics or be mistaken for drug/procedure effects based on operational policies

CASE 01 Detail Case

A Case of Misunderstanding of Drugs and Procedures in Functional Cosmetics

It is an expression case that can be perceived as having a medical effect beyond the efficacy range of functional cosmetics. Expressions that misidentify functional cosmetics with the same or similar level of effect as drugs\n or procedures\n may be misleading to consumers and may violate Article 13 of the 「Act on Fair Labeling and Advertising」 and the 「Cosmetics Act」.

02 - Status of applications for reporting this week

I'm sharing the proportion of reporting by type this week.

03 · This week's main issue — Examples of advertisement deliberation violations and misrepresentations of consumers

We share a case in which expressions that can cause consumer misconceptions have been identified in the process of providing project information.

1. medical device advertising violations

Details of report

Supporter reports have been received that the contents different from the approved efficacy and effects are being used in the process of advertising medical devices in the project story.

Details of confirmation

A review of advertising expressions and rewards information within the project identified the product as a licensed medical device for a specific purpose only. However, some expressions in the story have been confirmed to guide efficacy and effects beyond the scope of permission, so we have requested a story correction and taken related measures in consideration of the possibility of misunderstanding consumers.

2. Consumer misidentification report due to the use of award history

Details of report

Although the project story highlights and promotes a specific award history, reports have been received that there is a difference between the key functions evaluated at the time of the award and the actual reward composition, which could lead to consumer misconceptions.

Details of confirmation

As a result of the confirmation, the award history itself guided by the project was objectively confirmed, and it was difficult to see it as a false fact. However, even though there is a difference between the key functions or configurations evaluated at the time of the award and the rewards currently offered, the information is not sufficiently guided, indicating that consumers are likely to perceive the award history and the current rewards equally. In order to clearly guide the scope of the actual offer, we have made a request for correction and action on the relevant expression.

Operational Complement Direction

Based on the above case, Wadiz will continue to monitor to enhance the accuracy and transparency of project information and strengthen the inspection of false and exaggerated advertisements and expressions that are likely to mislead consumers.

04 · Summary of this week's operations

It was a week when we reviewed issues related to the misconception of supporters received through the AI monitoring and reporting channels, and conducted prompt processing and guidance according to operating policy standards.